What is he best known for?
The fields of study he is best known for:
Brian Wigdahl mainly focuses on Virology, Immunology, Virus, Gene expression and In vitro.
His Virology study integrates concerns from other disciplines, such as Disease and Gene.
His Virus research is multidisciplinary, incorporating perspectives in Medicinal plants, Long terminal repeat and Drug discovery.
His studies deal with areas such as T cell and Transcription factor, CREB as well as Gene expression.
The various areas that he examines in his In vitro study include Vaginal microbicide, Toxicity, Pharmacology, In vivo and Microbicide.
His Immune system study which covers Virus latency that intersects with Herpes simplex virus, Antigen, Nucleotide and Molecular biology.
His most cited work include:
- Cellular reservoirs of HIV-1 and their role in viral persistence. (266 citations)
- Antiviral Potentials of Medicinal Plants (171 citations)
- Breaking Down the Barrier: The effects of HIV-1 on the Blood-Brain Barrier (140 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Virology, Immunology, Virus, Immune system and Cell biology.
The study incorporates disciplines such as Gene expression, Long terminal repeat and Antibody in addition to Virology.
His Immunology research incorporates elements of Disease and Microbicide.
His research in Immune system intersects with topics in Proinflammatory cytokine and Cytotoxic T cell.
His Cell biology research includes themes of Secretion, Cell culture and T cell.
Brian Wigdahl works mostly in the field of Viral replication, limiting it down to concerns involving Transcription and, occasionally, CRISPR and Genetic variation.
He most often published in these fields:
- Virology (37.04%)
- Immunology (31.94%)
- Virus (18.52%)
What were the highlights of his more recent work (between 2017-2021)?
- CRISPR (18.06%)
- Computational biology (11.57%)
- Guide RNA (10.65%)
In recent papers he was focusing on the following fields of study:
Brian Wigdahl mostly deals with CRISPR, Computational biology, Guide RNA, Transcription and Cas9.
His CRISPR study incorporates themes from Virology and Provirus.
His work on Virus is typically connected to Car t cells as part of general Virology study, connecting several disciplines of science.
His Computational biology research includes elements of DNA and Palindrome.
His work deals with themes such as Genetic variation and Cell biology, which intersect with Transcription.
Brian Wigdahl works mostly in the field of Cas9, limiting it down to topics relating to DNA sequencing and, in certain cases, Viral quasispecies and In silico.
Between 2017 and 2021, his most popular works were:
- Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection. (29 citations)
- Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection. (29 citations)
- Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients. (23 citations)
In his most recent research, the most cited papers focused on:
Brian Wigdahl spends much of his time researching Cas9, CRISPR, Guide RNA, Computational biology and Transcription.
His Cas9 research incorporates themes from Genome editing, Virus, Disease and Effector.
As part of his studies on CRISPR, he frequently links adjacent subjects like Virology.
His Guide RNA research is multidisciplinary, relying on both Chromatin, DNA, Cleavage and Transcriptome.
His research integrates issues of Proviral genome, In silico, DNA sequencing and Viral quasispecies in his study of Computational biology.
His research investigates the connection with Transcription and areas like Viral replication which intersect with concerns in Cell biology and Transactivation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
